Jennifer Lowe

Dr. Jennifer Lowe

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SGSabrina Ribeiro Gonsalez
Sabrina Ribeiro Gonsalez
ACAline Leal Cortês
Aline Leal Cortês
RSRaquel Costa da Silva
Raquel Costa da Silva
Jennifer LoweJennifer Lowe
Jennifer Lowe
MPMinolfa C. Prieto
Minolfa C. Prieto
Lucienne S. LaraLucienne S. Lara
Lucienne S. Lara

9 March 2017 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
Jennifer LoweJennifer Lowe
Jennifer Lowe
RTRosilane Taveira‐Da‐Silva
Rosilane Taveira‐Da‐Silva
EHElaine Hilário‐Souza
Elaine Hilário‐Souza

1 June 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Jennifer LoweJennifer Lowe
Jennifer Lowe
AVAdalberto Vieyra
Adalberto Vieyra
PCPatrice Catty
Patrice Catty
FGFlorent Guillain
Florent Guillain
EMElisabeth Mintz
Elisabeth Mintz
MCMartine Cuillel
Martine Cuillel
Ccc2p is homologous to the human Menkes and Wilson copper ATPases and is herein studied as a model for human copper transport. Most studies to date have sought to understand how mutations in the human Menkes or Wilson genes impair copper homeostasis and induce disease. Here we analyze whether eight conserved amino acids of the transmembrane domain are important for copper transport. Wild-type Ccc2p and variants were expressed in a ccc2-Δ yeast strain to check whether they were able to restore copper transport by complementation. Wild-type Ccc2p and variants were also expressed in Sf9 cells using baculovirus to study their enzymatic properties on membrane preparations. The latter system allowed us to measure a copper-activated ATPase activity of about 20 nmol/mg/min for the wild-type Ccc2p at 37 °C. None of the variants was as efficient as the wild type in restoring copper homeostasis. The mutation of each cysteine of the 583CPC585 motif into a serine resulted in nonfunctional proteins that could not restore copper homeostasis in yeast and had no ATPase activity. Phosphorylation by ATP was still possible with the C583S variant, although it was not possible with the C585S variant, suggesting that the cysteines of the CPC motif have a different role in copper transport. Cys583 would be necessary for copper dissociation and/or enzyme dephosphorylation and Cys585 would be necessary for ATP phosphorylation, suggesting a role in copper binding.

1 August 2017 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
FFFernanda M. Ferrão
Fernanda M. Ferrão
LCLuiza H. D. Cardoso
Luiza H. D. Cardoso
HDHeather A. Drummond
Heather A. Drummond
XLXiao C. Li
Xiao C. Li
JZJia L. Zhuo
Jia L. Zhuo
Jennifer LoweJennifer Lowe
Jennifer Lowe
ANG II has many biological effects in renal physiology, particularly in Ca2+handling in the regulation of fluid and solute reabsorption. It involves the systemic endocrine renin-angiotensin system (RAS), but tissue and intracrine ANG II are also known. We have shown that ANG II induces heterodimerization of its AT1and AT2receptors (AT1R and AT2R) to stimulate sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) activity. Thus, we investigated whether ANG II-AT1R/AT2R complex is formed and internalized, and also examined the intracellular localization of this complex to determine how its effect might be exerted on renal intracrine RAS. Living cell imaging of LLC-PK1cells, quantification of extracellular ANG II, and use of the receptor antagonists, losartan and PD123319, showed that ANG II is internalized with AT1R/AT2R heterodimers as a complex in a microtubule-dependent and clathrin-independent manner, since colchicine—but not Pitstop2—blocked this process. This result was confirmed by an increase of β-arrestin phosphorylation after ANG II treatment, clathrin-mediated endocytosis being dependent on dephosphorylation of β-arrestin. Internalized ANG II colocalized with an endoplasmic reticulum (ER) marker and increased levels of AT1R, AT2R, and PKCα in ER-enriched membrane fractions. This novel evidence suggests the internalization of an ANG II-AT1/AT2complex to target ER, where it might trigger intracellular Ca2+responses.

1 May 2012 in Toxicon
Verified
Journal Article
Closed access
Jennifer LoweJennifer Lowe
Jennifer Lowe
JSJ. Souza-Menezes
J. Souza-Menezes
DFD.S. Freire
D.S. Freire
LML.J. Mattos
L.J. Mattos
RCR.C. Castiglione
R.C. Castiglione
RSR.M. Soares
R.M. Soares

28 February 2018 in Natural Product Research
Verified
Journal Article
Open access
PSPerla V. B. da Silva
Perla V. B. da Silva
MRMarianne M. Ramiro
Marianne M. Ramiro
EIEdna K. K. Iriguchi
Edna K. K. Iriguchi
WCWilliam A. Corrêa
William A. Corrêa
Jennifer LoweJennifer Lowe
Jennifer Lowe
RMRozanna M. Muzzi
Rozanna M. Muzzi
This study evaluated the hypoglycemic effect of the oil extracted from the Acrocomia aculeata pulp (OPAC) in normoglycemic rats and streptozotocin (STZ), fructose-induced diabetic rat models and its in vitro antioxidant and cytotoxic potential. OPAC (3, 30 or 300 mg/kg, v.o.) significantly decreased (p < 0.05) the high glucose levels induced by a high fructose-diet in rats. Persistent treatment with OPAC for 24 days also reduced the high plasmatic glucose induced by STZ. In normoglycemic animals, OPAC significantly decreased glucose levels. While A. aculeata oil exhibited good in vitro antioxidant activity, no sign of cytotoxicity was observed in LLC-PK1 cells (5–500 μg/mL). OPAC has antidiabetic and antioxidant activities without causing in vitro cytotoxicity.